No black box warning on record for Ioflupane I 123

As of the latest FDA labeling reviewed, Ioflupane I 123 (IOFLUPANE I-123) does not carry a black box warning. Standard warnings and precautions still apply — see the full Ioflupane I 123 medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Hypersensitivity reactions including dyspnea, edema, rash, erythema, and pruritus have been reported. Have treatment measures available prior to Ioflupane I 123 Injection administration. ( 5.1 ) Thyroid Accumulation of Iodine-123: Thyroid uptake of iodine-123 may result in an increased long-term risk for thyroid neoplasia. ( 2.2 , 5.2 ) Radiat

No black box warning on record for Ioflupane I 123

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Hypersensitivity reactions including dyspnea, edema, rash, erythema, and pruritus have been reported. Have treatment measures available prior to Ioflupane I 123 Injection administration. ( 5.1 ) Thyroid Accumulation of Iodine-123: Thyroid uptake of iodine-123 may result in an increased long-term risk for thyroid neoplasia. ( 2.2 , 5.2 ) Radiat

Ioflupane I 123 Black Box Warning

No black box warning on record for Ioflupane I 123

Other warnings & precautions

Ioflupane I 123 Black Box Warning

No black box warning on record for Ioflupane I 123

Other warnings & precautions